Each radiopaque implant contains 68 mg of etonogestrel; the release rate is approximately 60-70 μg/day in week 5-6 and has decreased to approximately 35-45 μg/day at the end of the first year, to approximately 30-40 μg/day at the end of the second year and to approximately 25-30 μg/day at the end of the third year. The innovative applicator is designed to be operated with one hand and to help facilitate correct subdermal insertion of the implant.
Implanon NXT is a radiopaque, non-biodegradable, progestagen-only, flexible implant preloaded in a sterile, ready-for-use, disposable applicator.
Excipients/Inactive Ingredients: Core: Ethylene vinyl acetate copolymer (28% vinyl acetate, 43 mg) barium sulfate (15 mg), magnesium stearate (0.1 mg).
Skin: Ethylene vinyl acetate copolymer (15% vinyl acetate, 15 mg).